Abnormal P‐wave terminal force in lead V 1 is a marker for atrial electrical dysfunction but not structural remodelling-Reference-Cited by-同舟云学术

Abnormal P‐wave terminal force in lead V 1 is a marker for atrial electrical dysfunction but not structural remodelling

Published:2021-06-30 Issue:5 Volume:8 Page:4055-4066
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Lebek Simon¹^ORCID,Wester Michael¹^ORCID,Pec Jan¹,Poschenrieder Florian²,Tafelmeier Maria¹,Fisser Christoph¹,Provaznik Zdenek³,Schopka Simon³,Debl Kurt¹,Schmid Christof³,Buchner Stefan⁴,Maier Lars S.¹,Arzt Michael¹,Wagner Stefan¹

Affiliation:

1. Department of Internal Medicine II University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 Germany

2. Department of Radiology University Hospital Regensburg Regensburg Germany

3. Department of Cardiothoracic Surgery University Hospital Regensburg Regensburg Germany

4. Department of Internal Medicine Cham Hospital Cham Germany

Funder

Else Kröner-Fresenius-Stiftung

Philips Respironics Foundation

Deutsche Forschungsgemeinschaft

Deutsche Herzstiftung

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13488

Reference29 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication

3. Left atrial size and risk of stroke in patients in sinus rhythm

4. Left Atrial Size and Function

5. Abnormal P-wave terminal force in lead V1 is associated with cardiac death or hospitalization for heart failure in prior myocardial infarction

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal alterations in P-wave electrocardiographic metrics post patent foramen ovale closure: a retrospective study;Anatolian Current Medical Journal;2024-01-15

2. CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model;Journal of Clinical Investigation;2024-01-02

3. Prognostic Value of PtfV1 in Long-Term Outcomes of Patients with Unstable Angina;International Journal of General Medicine;2023-12

4. Association between P-wave terminal force in lead V1 and extent of left atrial low-voltage substrate in older patients with paroxysmal atrial fibrillation;Journal of Interventional Cardiac Electrophysiology;2023-11-30

5. Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice;Circulation;2023-11-07